ALB
A stranger
ALIVER: Development of DIALIVE a novel Liver Dialysis Device for the treatment of patients with Acute on Ch...
ALBUTEC GMBH
participó en un
H2020:
H2020-SC1-2016-2017
Liver disease incidence is increasing and about 170K patients die from liver failure each year in Europe. In liver failure, the accumulation...
2016-12-01 - 2021-01-31 | financed
2016-12-01 - 2021-01-31 | financed
ACROBAT: Adsorbent carbons for the removal of biologically active toxins
ALBUTEC GMBH
participó en un
FP7:
The aim of the project is to manufacture an adsorbent carbon based cartridge within a perfusion system for the removal of strongly, protein...
financed
financed
* No data from the current company are not available.